A convenient biomimetic synthesis of optically active putative neurotoxic metabolites of MDMA ("ecstasy") from R-(-)- and S-(+)-N-methyl-α-methyldopamine precursors.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Organic and biomolecular chemistry

• Publication date

  2012-05-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c2ob25245gPMID 22456797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans.

  2012cited by this paper
• Synthesis and neurotoxicity profile of 2,4,5-trihydroxymethamphetamine and its 6-(N-acetylcystein-S-yl) conjugate.

  2011cited by this paper
• Investigation on the Enantioselectivity of the Sulfation of the Methylenedioxymethamphetamine Metabolites 3,4-Dihydroxymethamphetamine and 4-Hydroxy-3-Methoxymethamphetamine using the Substrate-Depletion Approach

  2011cited by this paper
• Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) Enantiomers In Vitro and in the MPTP-Lesioned Primate: R-MDMA Reduces Severity of Dyskinesia, Whereas S-MDMA Extends Duration of ON-Time

  2011cited by this paper
• Anodic oxidation of catechols in the presence of alpha-oxoketene N,N-acetals with a tetrahydropyrimidine ring: selective alpha-arylation reaction.

  2010cited by this paper
• Electrochemical oxidation of substituted catechols in the presence of pyrazol-5-ones: characterization of products and reaction mechanism

  2010cited by this paper
• Neurotoxicity of ecstasy (MDMA): an overview.

  2010cited by this paper
• Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(-)-HHMA): comparison with related catecholamines.

  2010cited by this paper
• Endocrine and Neurochemical Effects of 3,4-Methylenedioxymethamphetamine and Its Stereoisomers in Rhesus Monkeys

  2010cited by this paper
• The Role of Human UDP-Glucuronyltransferases on the Formation of the Methylenedioxymethamphetamine (Ecstasy) Phase II Metabolites R- and S-3-Methoxymethamphetamine 4-O-Glucuronides

  2009cited by this paper
• Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity

  2009cited by this paper
• Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview

  2009cited by this paper
• A Facile Synthesis of α‐Aryl α‐Oxoheterocyclic Ketene N,N‐Acetals Bearing an Electron‐Rich Catechol Subunit–An Electrochemical Oxidative Approach

  2009cited by this paper
• On the Mechanisms Underlying 3,4-Methylenedioxymethamphetamine Toxicity: The Dilemma of the Chicken and the Egg

  2009cited by this paper
• Neurotoxic Thioether Adducts of 3,4-Methylenedioxymethamphetamine Identified in Human Urine After Ecstasy Ingestion

  2009cited by this paper
• Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine and Its Enantiomers in Mice: Pharmacokinetic Considerations

  2009cited by this paper
• Discriminative Stimulus Effects of Psychostimulants and Hallucinogens in S(+)-3,4-Methylenedioxymethamphetamine (MDMA) and R(−)-MDMA Trained Mice

  2009cited by this paper
• Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.

  2009cited by this paper
• Accumulation of Neurotoxic Thioether Metabolites of 3,4-(±)-Methylenedioxymethamphetamine in Rat Brain

  2008cited by this paper
• Bioactive alkenylphenols from Piper obliquum.

  2008cited by this paper
• Serotonergic neurotoxic thioether metabolites of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): synthesis, isolation, and characterization of diastereoisomers.

  2008cited by this paper
• Pronounced steric effects of substituents in the nazarov cyclization of aryl dienyl ketones.

  2008cited by this paper
• The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxy-Methamphetamine and Its Enantiomers

  2008cited by this paper
• Two-component liquid crystals as chiral reaction media: highly enantioselective photodimerization of an anthracene derivative driven by the ordered microenvironment.

  2008cited by this paper
• In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.

  2008cited by this paper
• Bacterial plate assays and electrochemical methods: an efficient tandem for evaluating the ability of catechol-thioether metabolites of MDMA ("ecstasy") to induce toxic effects through redox-cycling.

  2007cited by this paper
• Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms

  2007cited by this paper
• Regiosymmetric poly(dialkylphenylenedioxythiophene)s: electron-rich, stackable pi-conjugated nanoribbons.

  2007cited by this paper
• Neurotoxicity mechanisms of thioether ecstasy metabolites.

  2007cited by this paper
• Synthesis and cyclic voltammetry studies of 3,4-methylenedioxymethamphetamine (MDMA) human metabolites

  2007cited by this paper
• 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

  2006cited by this paper
• Total synthesis and stereochemical confirmation of manassantin A, B, and B1.

  2006cited by this paper
• A comparative study on the acute and long‐term effects of MDMA and 3,4‐dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

  2005cited by this paper
• A one-pot regiospecific synthesis of highly functionalized 1,4-benzodioxin derivatives from an electrochemically induced Diels-Alder reaction.

  2005cited by this paper
• Electroorganic synthesis of catecholthioethers.

  2005cited by this paper
• A new family of small molecules to probe the reactivation of mutant p53.

  2005cited by this paper
• Serotonergic Neurotoxic Metabolites of Ecstasy Identified in Rat Brain

  2005cited by this paper
• Thioether Metabolites of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Inhibit Human Serotonin Transporter (hSERT) Function and Simultaneously Stimulate Dopamine Uptake into hSERT-Expressing SK-N-MC Cells

  2004cited by this paper
• Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).

  2004cited by this paper
• The Role of Metabolism in 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylenedioxymethamphetamine (Ecstasy) toxicity

  2004cited by this paper
• Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms.

  2003cited by this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003cited by this paper
• Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

  2003cited by this paper
• Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites.

  2002cited by this paper
• Electroorganic synthesis of new benzofuro[2,3-d]pyrimidine derivatives.

  2002cited by this paper
• Improved syntheses of α-BOC-aminoketones from α-BOC-amino-Weinreb amides using a pre-deprotonation protocol

  2002cited by this paper
• 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans.

  2001cited by this paper
• 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

  2001cited by this paper
• Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.

  2001cited by this paper
• Diastereoselective cyclopentane construction

  2000cited by this paper
• Total Synthesis of (−)-Colchicine by an Oxyallyl [4+3] Cycloaddition

  2000cited by this paper
• Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity.

  1999cited by this paper
• Electrochemical oxidation of N-acyldopamines and regioselective reactions of their quinones with N-acetylcysteine and thiourea.

  1998cited by this paper
• Perfluorinated Cyclic and Acyclic Keto−Enol Systems: A Remarkable Contrast

  1997cited by this paper
• 2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations.

  1997cited by this paper
• Characterization of Products from the Reactions of Dopamine Quinone with N-Acetylcysteine

  1996cited by this paper
• Oxidation chemistry of (-)-norepinephrine in the presence of L-cysteine.

  1996cited by this paper
• Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats.

  1996cited by this paper
• Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease.

  1996cited by this paper
• Metabolism of 5-(glutathion-S-yl)-alpha-methyldopamine following intracerebroventricular administration to male Sprague-Dawley rats.

  1995cited by this paper
• Influence of glutathione on the oxidation chemistry of the catecholaminergic neurotransmitter dopamine

  1995cited by this paper
• Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease.

  1994cited by this paper
• Organometallic compounds of Group III. 49. Reductive deoxygenation of ketones and secondary alcohols by organoaluminum Lewis acids

  1992cited by this paper
• Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA).

  1992cited by this paper
• The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats.

  1989cited by this paper
• Studies of the mechanistic diversity of sodium cyanoborohydride reduction of tosylhydrazones

  1989cited by this paper
• Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons.

  1988cited by this paper
• Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices.

  1986cited by this paper
• Reductive deoxygenation of aryl aldehydes and ketones and benzylic, allylic, and tertiary alcohols by zinc iodide-sodium cyanoborohydride

  1986cited by this paper
• Zinc-Modified Cyanoborohydride as a Selective Reducing Agent

  1985cited by this paper
• Friedel-Crafts acylation with N-(trifluoroacetyl)-.alpha.-amino acid chlorides. Application to the preparation of .beta.-arylalkylamines and 3-substituted 1,2,3,4-tetrahydroisoquinolines

  1984cited by this paper
• Selective deoxygenation of ketones and aldehydes including hindered systems with sodium cyanoborohydride

  1973cited by this paper

• An electrochemical access to 2-amino-2,3-dihydro-1,4-benzodioxanes derived from hydroxytyrosol.

  2024cites this paper
• Neurotoxicity in Psychostimulant and Opiate Addiction

  2021cites this paper
• Expanding and exploring the bioconjugation toolbox

  2016cites this paper
• Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans

  2016cites this paper
• Polycyclic Polyprenylated Xanthones from Symphonia globulifera: Isolation and Biomimetic Electrosynthesis.

  2015cites this paper
• A Study of the Prevalence of Psychiatric Disorders in Patients with Methamphetamine-Induced Psychosis

  2015cites this paper
• Strain-promoted oxidation-controlled cyclooctyne-1,2-quinone cycloaddition (SPOCQ) for fast and activatable protein conjugation.

  2015cites this paper
• Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and its Phase I and II Metabolites following Controlled MDMA Administration to Humans

  2015cites this paper
• Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans

  2015cites this paper
• 8.12 Reduction of C X to CH 2

  2014cites this paper